𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Safety and immunogenicity of a modified process hepatitis B vaccine in healthy neonates

✍ Scribed by Gianmaria Minervini; Barbara J. McCarson; Keith S. Reisinger; Jason C. Martin; Jon E. Stek; Barbara M. Atkins; Karin B. Nadig; Vladimir Liska; Florian P. Schödel; Prakash K. Bhuyan


Book ID
116964655
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
218 KB
Volume
30
Category
Article
ISSN
0264-410X

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Safety and immunogenicity of a recombina
✍ E. Dandolos; A. Roumeliotou-Karayannis; S. C. Richardson; Prof. G. Papaevangelou 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 340 KB

A hepatitis B vaccine produced in yeast by recombinant DNA technology was evaluated using 5-micrograms and 10-micrograms doses in a randomized trial lasting 7 months in 110 male armed forces recruits aged 17-19 years. Results were compared to those of an identical trial of a plasma-derived vaccine.